The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of ALX148, a CD47 blocker, alone and in combination with established anticancer antibodies in patients with advanced malignancy and non-Hodgkin lymphoma.
 
Nehal J. Lakhani
Research Funding - Abbvie (Inst); Alexion Pharmaceuticals (Inst); Alexo Therapeutics (Inst); Amgen (Inst); ArQule (Inst); Asana Biosciences (Inst); Ascentage Pharma (Inst); BeiGene (Inst); Cerulean Pharma (Inst); Constellation Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Dicerna (Inst); Forty Seven (Inst); Loxo (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst); Symphony Evolution (Inst); TaiRx, Inc. (Inst)
 
Patricia LoRusso
Leadership - Agios; Five Prime Therapeutics; Halozyme; Roche/Genentech
Honoraria - Genentech/Roche
Consulting or Advisory Role - Alexion Pharmaceuticals; ARIAD; CytomX Therapeutics; Genentech; Genentech; Genmab; Glenmark; Ignyta; Menarini; Novartis; Omniox; Takeda
Research Funding - Alexion Pharmaceuticals; Boehringer Ingelheim; Genentech (Inst); Immunogen (Inst); Merrimack (Inst); Novartis (Inst); Pfizer; Taiho Pharmaceutical (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; Genentech/Roche
 
Navid Hafez
No Relationships to Disclose
 
Anuradha Krishnamurthy
No Relationships to Disclose
 
Timothy J. O'Rourke
Research Funding - Asana Biosciences (Inst)
 
Manali K. Kamdar
Speakers' Bureau - Seagen
 
Philip Fanning
Employment - Alexo Therapeutics
Stock and Other Ownership Interests - Alexo Therapeutics
Travel, Accommodations, Expenses - Alexo Therapeutics
 
Yonggang Zhao
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Johnson & Johnson (I)
Consulting or Advisory Role - Alexo Therapeutics; AstraZeneca/MedImmune; Navitor Pharmaceuticals; Sol-Gel
 
Feng Jin
Consulting or Advisory Role - Alexo Therapeutics
 
Hong Wan
Employment - Alexo Therapeutics
Leadership - Alexo Therapeutics
Stock and Other Ownership Interests - Alexo Therapeutics
Travel, Accommodations, Expenses - Alexo Therapeutics
 
Jaume Pons
Employment - Alexo Therapeutics
Leadership - Alexo therapeutics
Stock and Other Ownership Interests - Pfizer
Patents, Royalties, Other Intellectual Property - Inventor in many patents owned by Pfizer, Teva and Alexo Therapeutics
 
Sophia Randolph
Employment - Alexo Therapeutics; Pfizer
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Carrick Therapeutics; venBio
 
Wells A. Messersmith
Consulting or Advisory Role - Gilead Sciences; Purdue Pharma; Tanabe Research
Research Funding - Aduro Biotech; Alexo Therapeutics; Immunomedics; OncoMed; Pfizer; Roche/Genentech; Takeda